Loading...
Market
What will be the next disease target for mRNA vaccine development announced by a major pharmaceutical company by the end of 2024?
2
Resolution / Starting Odds
Influenza • 25%
Zika • 25%
HIV • 25%
Other • 25%
Official announcements from major pharmaceutical companies like Moderna, Pfizer, or BioNTech
Story
Nobel Laureates' mRNA Technology Could Have Changed Pandemic Course If Available in May 2020
Nov 24, 2024, 02:50 PM
mRNA technology, developed by Nobel Prize laureates, has been pivotal in the rapid creation of COVID-19 vaccines. This technology, which has shown potential for developing vaccines against other diseases such as influenza, Zika, and HIV, could have significantly altered the course of the pandemic if available as early as May 2020 instead of February 2021. A new study also highlights the potential of mRNA in cancer immunotherapy, demonstrating its ability to speed up messenger RNA translation in cytoplasm and effectively inhibit tumor growth.
View original story
Similar markets
Influenza • 25%
Zika Virus • 25%
HIV • 25%
Other • 25%
Yes • 50%
No • 50%
Cancer Vaccine • 25%
Rare Disease Treatment • 25%
Personalized Medicine • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Sanofi • 25%
Other • 25%
COVID-19 • 25%
Influenza • 25%
HIV • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Cancer • 25%
Autoimmune disorders • 25%
Infectious diseases • 25%
Other • 25%
Yes • 50%
No • 50%
